Suppr超能文献

曲马多致一过性人格解体/现实解体综合征。

Transient depersonalisation/derealisation syndrome from tramadol.

机构信息

Division of Toxicology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand

Department of Psychiatry and Center of Excellence in Transgender Health, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.

出版信息

BMJ Case Rep. 2023 Jun 6;16(6):e254909. doi: 10.1136/bcr-2023-254909.

Abstract

Depersonalisation/derealisation (DD) syndrome is often associated with severe traumatic experiences and the use of certain medications. Our patient reported experiencing a transient DD phenomenon a few hours after taking 37.5 mg of tramadol, together with etoricoxib, acetaminophen and eperisone. His symptoms subsided upon tramadol discontinuation, suggesting the possibility of tramadol-induced DD. A study of the patient's cytochrome P450 (CYP) 2D6 polymorphism, which mainly metabolises tramadol, indicated normal metaboliser status with reduced function. The concomitant administration of the CYP2D6 inhibitor, etoricoxib, would have led to higher concentrations of the serotonergic parent tramadol, providing an explanation for the patient's symptoms.

摘要

人格解体/现实解体(DD)综合征常与严重的创伤经历和某些药物的使用有关。我们的患者报告称,在服用 37.5 毫克曲马多、依托考昔、对乙酰氨基酚和乙哌立松几小时后,出现一过性 DD 现象。停用曲马多后,他的症状缓解,提示曲马多引起 DD 的可能性。对患者细胞色素 P450(CYP)2D6 多态性的研究表明,其主要代谢物曲马多的代谢正常,但功能降低。同时使用 CYP2D6 抑制剂依托考昔会导致血清素前体曲马多的浓度升高,这可以解释患者的症状。

相似文献

1
Transient depersonalisation/derealisation syndrome from tramadol.
BMJ Case Rep. 2023 Jun 6;16(6):e254909. doi: 10.1136/bcr-2023-254909.
2
Efficacy of Tramadol for Pain Management in Patients Receiving Strong Cytochrome P450 2D6 Inhibitors.
Pharmacotherapy. 2019 Jun;39(6):724-729. doi: 10.1002/phar.2269. Epub 2019 May 20.
3
Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Anesth Analg. 2010 Aug;111(2):544-9. doi: 10.1213/ANE.0b013e3181e3d87c. Epub 2010 Jun 28.
8
CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.
Appl Nurs Res. 2017 Dec;38:107-110. doi: 10.1016/j.apnr.2017.10.001. Epub 2017 Oct 7.
9
Tramadol oral solution (Qdolo) for pain.
Med Lett Drugs Ther. 2021 May 31;63(1625):83-84.

本文引用的文献

1
CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia.
Pharmgenomics Pers Med. 2020 Nov 2;13:543-551. doi: 10.2147/PGPM.S276230. eCollection 2020.
2
Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder.
Med Hypotheses. 2019 Dec;133:109407. doi: 10.1016/j.mehy.2019.109407. Epub 2019 Sep 24.
3
Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD).
BMC Psychol. 2013 Oct 28;1(1):20. doi: 10.1186/2050-7283-1-20. eCollection 2013.
4
PharmGKB summary: tramadol pathway.
Pharmacogenet Genomics. 2014 Jul;24(7):374-80. doi: 10.1097/FPC.0000000000000057.
5
Dissociative disorders in DSM-5.
Annu Rev Clin Psychol. 2013;9:299-326. doi: 10.1146/annurev-clinpsy-050212-185531. Epub 2013 Feb 1.
6
Methylphenidate in depersonalization disorder: a case report.
Actas Esp Psiquiatr. 2011 Jan-Feb;39(1):75-8. Epub 2011 Jan 1.
9
Depersonalization-derealization syndrome induced by reboxetine.
Swiss Med Wkly. 2003 Jul 12;133(27-28):398-9. doi: 10.4414/smw.2003.10195.
10
Effect of naloxone therapy on depersonalization: a pilot study.
J Psychopharmacol. 2001 Jun;15(2):93-5. doi: 10.1177/026988110101500205.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验